Escherichia coli O157:H7 Hemorrhagic Colitis

New England Journal of Medicine

Volumn 318, Issue 25, 1988, Pages 1697-

  Tarr, Phillip I ^a   Neill, Marguerite A ^a   Christie, Dennis L ^b   Anderson, Donald E ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c SACRED HEART MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; METRONIDAZOLE; NORFLOXACIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; ESCHERICHIA COLI; HEMORRHAGIC COLITIS; HUMAN; LETTER; PRIORITY JOURNAL;

ANTIBIOTICS; COLITIS; ESCHERICHIA COLI INFECTIONS; GASTROINTESTINAL HEMORRHAGE; HEMOLYTIC-UREMIC SYNDROME; HUMAN;

EID: 0023932003     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198806233182515     Document Type: Letter

References (13)

1. Carter AO, Borczyk AA, Carlson JAK, et al. A severe outbreak of Escherichia coli O157:H7–associated hemorrhagic colitis in a nursing home. N Engl J Med 1987; 317: 1496–500.
2. Sack RB. Enterohemorrhagic Escherichia coli. N Engl J Med 1987; 317: 1535–7.
3. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; 1: 619–20.
4. Gransden WR, Damm MA, Anderson JD, Carter JE, Lior H. Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis 1986; 154: 522–4.
5. Neill MA, Tarr PI, Clausen CR, Christie DL, Hickman RO. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics 1987; 80: 37–40.
6. Tarr PI, Neill MA, Clausen CR, et al. Results of a thirty month prospective study of enteric pathogens in the hemolytic uremic syndrome. Proceedings of the International Symposium and Workshop on Verocytotoxin-producing E. coli, Toronto, July 13–15, 1987. New York: Alan R. Liss (in press).
7. Karmali MA. HUS and verocytotoxin-producing E. coli. Proceedings of the International Symposium and Workshop on Verocytotoxin-Producing E. coli, Toronto, July 13–15, 1987. New York: Alan R. Liss (in press).
8. Remuzzi G, principal discussant. HUS and TTP: variable expression of a single entity. Kidney Int 1987; 32: 292–308.
9. Butler T, Islam MR, Azad MAK, Jones PK. Risk factors for the development of hemolytic uremic syndrome during shigellosis. J Pediatr 1987; 110: 894–7.
10. Karmali MA, Petric M, Lim C, Cheung R, Arbus GS. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol 1985; 22: 614–9.
11. Karch H, Strockbine NA, O'Brien AD. Growth of Escherichia coli in the presence of trimethoprim–sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiol Lett 1986; 35: 141–5.
12. Salazar-Lindo E, Sack RB, Chea-Woo E, et al. Early treatment with erythromycin of Campylobacter jejuni–associated dysentery in children. J Pediatr 1986; 109: 355–60.
13. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308: 681–5.